Choosing an appropriate DME treatment is not always stress free. Paying for it should be. That’s why the ILUVIEN AccessPlus Program offers a range of financial assistance options that may help cover your specific needs.
If your eye doctor prescribes ILUVIEN, AccessPlus Financial Assistance Services may be able to help find options to assist you with your out-of-pocket costs.*
The ILUVIEN CoPay Program provides copay assistance for eligible, commercially insured patients with out-of-pocket costs that exceed $25.†
We’re here to help you embrace all of life’s amazing moments. The ILUVIEN Patient Assistance Program can provide FREE treatment for qualified uninsured and rendered uninsured patients. Apply today.‡
You always have options in life. That includes paying for appropriate DME treatment. Independent Financial Assistance Foundations are independent entities that provide financial assistance for patients insured by a government payer.
Contact AccessPlus today to learn more.
Call 1-844-445-8843 (option 3)
*Limitations apply. Payment assistance programs are for qualified insured and uninsured patients who are eligible for ILUVIEN.
†Limitations apply. The ILUVIEN CoPay Program does not apply to patient cost sharing for the injection procedure, diagnostic tests, or other costs associated with ILUVIEN treatment.
‡Limitations apply. The ILUVIEN Patient Assistance Program does not provide assistance for the injection procedure, diagnostic tests, or other costs associated with the administration of ILUVIEN.
INDICATION AND IMPORTANT SAFETY INFORMATION
ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.
ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Learn about the benefits of ILUVIEN, inspiring patient stories, financial assistance and more. We will keep emails to a minimum and only send you relevant, useful information!